FoundationOne CDx receives regulatory approval in Japan

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The Ministry of Health, Labour and Welfare of Japan has approved FoundationOne CDx as a comprehensive genomic profiling test for all solid tumors and a broad companion diagnostic for individuals living with advanced cancer.

To access this subscriber-only content please log in or renew your subscription.

Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Login